Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors in Breast Cancer in Egypt
NCT07487129Phase 4Completed
- Sponsor
- Beni Suef University
- Start
- Aug 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of palbociclib, ribociclib, abemaciclib in breast cancer, sponsored by Beni Suef University. Started Aug 2024; status: completed.
02
Drugs
palbociclibribociclibabemaciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07487129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07487129.